Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä
³»   ¿ë
Âü¿© ¿¬±¸¿ø ÀÓÀ翵 ½ÇÀå/±èÁøÀ̠åÀÓ¿¬±¸¿ø/Á¤µ¿¿í ºÎ¼±ÀÓ¿¬±¸¿ø
ÆíÁý ÀÌÁÖÇÏ ÁÖÀÓ¿¬±¸¿ø


3. ¾à»ç´ë»ó ÁúÀû¿¬±¸ Á¶»ç
º» ÆÄÆ®¿¡¼­´Â °ø°ø½É¾ß¾à±¹ ¿î¿µ ¾à»çµéÀÇ ¿î¿µ µ¿±â ¹× °æÇè, ¼öÇà ¿ªÇÒ, »ç¾÷¿¡ ÀνÄÀ» Á¶»çÇϰíÀÚ, 2020³â Á¦ÁÖµµ¿¡¼­ °ø°ø½É¾ß¾à±¹À» ¿î¿µ ÁßÀΠ7¸íÀÇ ¾à»ç¿¡°Ô ¿¬¶ôÀ» ÃëÇØ ¿¬±¸Âü¿© ¹× °³ÀÎÁ¤º¸È°¿ë¿¡ µ¿ÀÇÇÑ 5¸íÀ» ¹æ¹®ÇØ Á¶»çÇß´Ù.

Á¶»ç´ë»óÀÚ ¹× ¿î¿µ¾à±¹ Æ¯¼ºÀº ´ÙÀ½°ú °°´Ù. 4°³ÀÇ ¾à±¹Àº À¾¡¤¸é¿¡, ³ª¸ÓÁö 1°³´Â µ¿¿¡ À§Ä¡Çß´Ù. ¿î¿µ ¾à»çÀÇ ¿¬·É´ë´Â 50´ë 2¸í, 60´ë 1¸í, 70´ë 2¸íÀ¸·Î ´Ù¼Ò ³ôÀº ÆíÀ̾ú°í, ¼ºº°Àº ³²¼ºÀÌ 2ÀÎ, ¿©¼ºÀÌ 3ÀÎÀ̾ú´Ù. 

À¾¡¤¸é ¼ÒÀç 4°³ ¾à±¹Àº Á¦ÁÖµµ °ø°ø½É¾ß¾à±¹ Ãʱ⿡ Âü¿©ÇÏ¿© Áö¼ÓÀûÀ¸·Î ¿î¿µÇϰí ÀÖ¾ú´Ù. ÁÖ ¿î¿µÀϼö´Â ÁÖ 6ÀÏÀÌ 2°³ ¾à±¹, ÁÖ 3ÀÏÀÌ 3°³ ¾à±¹À̾ú´Ù. ¿î¿µ½Ã°£´ë´Â »ç¾÷¿¡¼­ »çÀü¿¡ Á¤ÇØÁø ¹Ù¿Í °°ÀÌ, À¾¡¤¸é ¼ÒÀ砾౹Àº 20¡­23½Ã, µ¿ ¼ÒÀ砾౹Àº 22¡­24½Ã¿´´Ù. ±Ù¹«¾à»ç¸¦ °í¿ëÇÑ °÷Àº 1°³ ¾à±¹, Á÷¿øÀ» °í¿ëÇÑ °÷Àº 2°³ ¾à±¹À̾ú´Ù.  

°ø°ø½É¾ß¾à±¹ ¿î¿µ ¾à»çµéÀÇ µ¿±â ¹× °æÇè, ¼öÇà ¿ªÇÒ, »ç¾÷¿¡ ´ëÇÑ ÀνÄÀ» Á¶»çÇϱâ À§ÇØ °³º° ½ÉÃþ ÀÎÅͺ並 ¼öÇàÇß´Ù. ±¸Ã¼ÀûÀ¸·Î ¿î¿µ µ¿±â, ¿î¿µ ¾Ö·Î»çÇ×, ¹æ¹®È¯ÀڠƯ¼º¿¡ µû¸¥ Á¶Ä¡, »ç¾÷ÀÇ Àü¸Á°ú Çʿ伺¿¡ ´ëÇØ Áú¹®Çß°í, ¹Ý±¸Á¶È­µÈ Áú¹®Áö¸¦ ÀÌ¿ëÇß´Ù. Áú¹®Áö¿¡ Æ÷ÇԵȠÁÖ¿ä Áú¹®Àº ´ÙÀ½°ú °°´Ù<Ç¥2 ÂüÁ¶>. 


º» ÆÄÆ®¿¡¼­´Â °ø°ø½É¾ß¾à±¹ Âü¿© ¾à»çµéÀÇ ¿î¿µ µ¿±â ¹× °æÇè, ¼öÇà ¿ªÇÒ, »ç¾÷¿¡ ´ëÇÑ ÀνÄÀ» ÆÄ¾ÇÇß´Ù. ±× °á°ú ¾à»çµéÀº ½É¾ß ½Ã°£´ë ÀÇ·á¼­ºñ½º Á¢±Ù¼ºÀ» ³ôÀ̴µ¥ ±â¿©Çϴ µ¿½Ã¿¡ °ÔÀÌÆ®Å°ÆÛ ¿ªÇÒÀ» Çϰí ÀÖ¾ú´Ù. µû¶ó¼­ °ø°ø½É¾ß¾à±¹ »ç¾÷ÀÇ À¯Áö ¹× È®´ë¸¦ ÅëÇÑ Áö¿ª»çȸ °Ç°­°³¼± È¿°ú°¡ ±â´ëµÈ´Ù. ´Ù¸¸ °³ÀΠÂ÷¿øÀÇ ¿î¿µ µ¿±â¿¡ ÀÇÁ¸Çϰí ÀÖ¾î(°³ÀÎÀû Á¶°Ç, »ç¸í°¨ µî) ´ÙÀ½ ÁÖÀÚ¸¦ Ã£±â°¡ ¾î·Á¿ï °ÍÀ¸·Î »ý°¢µÈ´Ù. Âü¿© µ¶·Á¸¦ À§ÇØ ¼ö´çÀ» ¿Ã·ÁÁִ °ÍÀº È¿°ú°¡ ¾øÀ» °ÍÀÌ´Ù. 

»ç¾÷ Áö¼Ó ¹× È®´ë¸¦ À§Çؼ­´Â ¿î¿µ ÆíÀÇ °³¼±ÀÌ ÇÊ¿äÇØ º¸ÀδÙ. ÀÎÅͺ信¼­ ¾ð±ÞµÈ ¹Ù¿Í °°ÀÌ, ¾à»ç·Î¼­ ´Ù¸¥ Àǹ«¸¦ °¨¸éÇØ ÁÖ°í ÇʼöÀûÀΠ°³ÀΠ½Ã°£À» º¸ÀåÇϴ ¹æ½ÄÀÇ º¸»óÀÌ È¿°úÀûÀÏ °ÍÀ¸·Î ÆÇ´ÜµÈ´Ù. ´Ü °ø°ø½É¾ß¾à±¹ÀÇ º»·¡ ÃëÁöÀΠ½É¾ß ½Ã°£´ë ÀÇ·á ¼ö¿ä¿¡ ´ëÇÑ ¼­ºñ½º¸¦ Á¦°øÇؾߠÇѴٴ ´çÃÊÀÇ °øÀÍÀû ¸ñÀûÀÌ ¸íÈ®ÇØ, À̿͠Çö½Ç »çÀÌÀÇ ±ÕÇüÁ¡À» Ã£´Â °ÍÀÌ Áß¿äÇϰڴÙ. 

º» ¿¬±¸ÀÇ Á¦ÇÑÁ¡Àº Àü¼ö¿¡ ÇØ´çÇϴ 7¸íÀÇ ¾à»çµé Áß ¿¬±¸ Âü¿©¿¡ µ¿ÀÇÇÑ ¸ðµÎ¸¦ ÀÎÅͺä ÇßÁö¸¸, Á¦ÁÖµµÀÇ ¸éÀûÀÌ ³Ð°í ¼­·Î ´Ù¸¥ À¾¡¤¸éÀ» Ä¿¹öÇϰí Àֱ⿡ Á¤º¸°¡ Æ÷È­ »óÅ¿¡ À̸£·¶´Ù°í Çϱ⿡´Â ¹«¸®°¡ ÀÖ´Ù. ±×·³¿¡µµ ÀÇ·áÀÚ¿øÀÌ »ó´ëÀûÀ¸·Î ÀûÀº À¾¡¤¸é¿¡¼­ °ø°ø½É¾ß¾à±¹ Âü¿© ¾à»ç °æÇè, ¿ªÇÒ, ÀνĠµîÀ» Á¶»çÇϴ Àü¿¡ ¾ø´ø ½Ãµµ¸¦ Çß´Ù. 

µû¶ó¼­ ´Ù¸¥ ½Ã°ñ Áö¿ª¿¡¼­ °ø°ø½É¾ß¾à±¹À» ¿î¿µÇϰíÀÚ ÇÒ ¶§ ¾à»ç Âü¿©¸¦ Á¦°íÇÏ°í »ç¾÷À» À¯Áö ¹× È®´ëÇϴµ¥ °¡À̵å·Î¼­ È°¿ëÇÒ ¼ö ÀÖÀ» °ÍÀ̶ó ±â´ëÇÑ´Ù. ¶ÇÇÑ ÇâÈÄ µµÈ¸Áö °ø°ø½É¾ß¾à±¹ ¾à»çµé¿¡ ´ëÇÑ Á¶»ç¸¦ ¼öÇàÇÔÀ¸·Î½á, Áö¿ª »çÁ¤¿¡ µû¸¥ ÃÖÀûÈ­µÈ ¿î¿µ ¹æ½Ä µî ´õ Å« ÇÔÀǸ¦ ²ø¾î ³¾ ¼ö ÀÖ°Ú´Ù.

´ÙÀ½Àº Á¦ÁÖµµ °ø°ø½É¾ß¾à±¹ ¾à»ç ´ë»ó ÀÎÅͺäÇÑ ³»¿ë Áß ÀϺθ¦ ¹ßÃéÇÑ °ÍÀÌ´Ù. 


<´ÙÀ½È£¿¡ °è¼Ó>

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 904
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 782
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 761
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 767
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 252
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 521
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 462
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 507
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 450
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 392
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 467
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 455
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 488
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 435
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 444

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»